Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT06565390 · ClinicalTrials.gov registry record · NA

Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization

A NA study of Emergencies, sponsored by University of Alabama at Birmingham.

Recruiting
Registry status
NA
Development phase
700
Enrollment target
1
Study location

NCT06565390 is a NA study of Emergencies that is actively recruiting participants, run by University of Alabama at Birmingham. The registered enrollment target is 700 participants, below the 9,222-participant average among 11 other Emergencies trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT06565390, a NA study of Emergencies, is actively recruiting participants, sponsored by University of Alabama at Birmingham.

RECRUITING
Registry status
NA
Development phase
700 participants
Enrollment target
1
Study location

Study Summary

This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

Conditions Studied

Interventions

  • DEVICE Babies in the Owlet monitor group

Study Locations (1)

Alabama

  • University of Alabama at Birmingham - Birmingham

Trial Details

FieldValue
Enrollment Target 700 participants
Start Date 2025-09-11
Est. Completion 2030-12-31
Phase NA

Sponsor

University of Alabama at Birmingham

1,160 total trials

What the Registry Record Tells You About NCT06565390

The ClinicalTrials.gov registry entry for NCT06565390 describes a study currently listed as recruiting, categorized as NA. The registered enrollment target is 700 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 9,222-participant average among 11 other Emergencies trials with a reported enrollment target (92% lower). The listed sponsor is University of Alabama at Birmingham, which has 1,160 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Emergencies appearing as the primary indexed condition, and to 1 intervention - of which Babies in the Owlet monitor group is the first listed.

NCT06565390 reports 1 study location spanning 1 distinct geographic area - top geographies include Alabama.

Frequently Asked Questions

What is clinical trial NCT06565390 about?

NCT06565390 is a clinical study titled "Remote Oximeter Monitoring Post-discharge to Reduce Emergency Room Visits and Rehospitalization". This randomized clinical trial will determine the efficacy of remote patient monitoring using an Owlet OSS 3.0 pulse oximeter for the reduction of emergency room visits and high-acuity rehospitalizations among high-risk infants after NICU discharge.

What is the current status of trial NCT06565390?

This trial is currently recruiting. It is a NA study. The enrollment target is 700 participants. The study started on 2025-09-11. Estimated completion is 2030-12-31.

What conditions does trial NCT06565390 study?

This clinical trial studies the following conditions: Emergencies.

What interventions are being tested in trial NCT06565390?

The interventions under investigation include: Babies in the Owlet monitor group (DEVICE).

Who is sponsoring clinical trial NCT06565390?

This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT06565390 being conducted?

This trial has 1 study location across Alabama. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Emergencies

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.